The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

FEIBA 50 U/ml powder and solvent for solution for infusion

Baxalta Innovations GmbHPA2004/001/002

Main Information

Trade NameFEIBA 50 U/ml powder and solvent for solution for infusion
Active SubstancesFeiba
Dosage FormPowder and solvent for solution for infusion
Licence HolderBaxalta Innovations GmbH
Licence NumberPA2004/001/002

Group Information

ATC CodeB02BD Blood coagulation factors
B02BD03 factor VIII inhibitor bypassing activity


License statusAuthorised
Licence Issued28/05/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back